PMID: 8662892

Seibert FS, Linsdell P, Loo TW, Hanrahan JW, Clarke DM, Riordan JR
Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.
J Biol Chem. 1996 Jun 21;271(25):15139-45., [PubMed]
Sentences
No. Mutations Sentence Comment
64 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:64:83
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:64:43
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:64:75
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:64:168
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:64:51
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:64:67
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:64:59
status: NEW
view ABCC7 p.Ala1067Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:64:157
status: NEW
view ABCC7 p.Ala1067Thr details
The mature forms of the other six mutants (F1052V, K1060T, A1067T, G1069R, R1070W, R1070Q) were produced in relatively normal amounts (band C), although for A1067T and R1070W CFTR the ratio of the complex-glycosylated to core-glycosylated bands was significantly lower than for wild-type CFTR. Login to comment
71 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:71:83
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:71:43
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:71:75
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:71:168
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:71:51
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:71:67
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:71:59
status: NEW
view ABCC7 p.Ala1067Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:71:157
status: NEW
view ABCC7 p.Ala1067Thr details
The mature forms of the other six mutants (F1052V, K1060T, A1067T, G1069R, R1070W, R1070Q) were produced in relatively normal amounts (band C), although for A1067T and R1070W CFTR the ratio of the complex-glycosylated to core-glycosylated bands was significantly lower than for wild-type CFTR. Login to comment
81 ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:81:173
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:81:181
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:81:193
status: NEW
view ABCC7 p.Gly1069Arg details
This showed that the level of activity for cells expressing each CFTR mutant did approximately correspond to the amount of mature protein in the sample, i.e. in COS-1 cells F1052V, K1060T, and G1069R produced efflux levels similar to wild-type CFTR in accordance with a level of protein expression similar to wild type. Login to comment
82 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:82:20
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:82:8
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:82:0
status: NEW
view ABCC7 p.Ala1067Thr details
A1067T, R1070W, and R1070Q CFTR had significantly lower efflux levels and significantly lower protein expression than wild-type CFTR in COS-1 cells. Login to comment
88 ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 8662892:88:279
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 8662892:88:286
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 8662892:88:306
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 8662892:88:294
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 8662892:88:156
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 8662892:88:174
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 8662892:88:163
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:88:173
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:88:181
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:88:193
status: NEW
view ABCC7 p.Gly1069Arg details
Other disease-causing CFTR mutants, which are appropriately processed and trafficked to the plasma membrane, show defective ion conduction properties (e.g. R334W, R347H, and R347P; Sheppard et al., 1993; Tabcharani et al., 1993) or defective regulation of channel activity (e.g. G551S, G1244E, S1255P, and G1349D; Anderson and Welsh, 1992). Login to comment
89 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:89:20
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:89:8
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:89:0
status: NEW
view ABCC7 p.Ala1067Thr details
A1067T, R1070W, and R1070Q CFTR had significantly lower efflux levels and significantly lower protein expression than wild-type CFTR in COS-1 cells. Login to comment
94 ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:94:148
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:94:208
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:94:156
status: NEW
view ABCC7 p.Gly1069Arg details
As shown in Fig. 5, B and C, in some mutants this reduction in open probability was associated with a significant reduction in mean burst duration (F1052V, G1069R) or an increase in mean interburst duration (R1070W). Login to comment
95 ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 8662892:95:279
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 8662892:95:286
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 8662892:95:306
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 8662892:95:294
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 8662892:95:156
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 8662892:95:174
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 8662892:95:163
status: NEW
view ABCC7 p.Arg347His details
Other disease-causing CFTR mutants, which are appropriately processed and trafficked to the plasma membrane, show defective ion conduction properties (e.g. R334W, R347H, and R347P; Sheppard et al., 1993; Tabcharani et al., 1993) or defective regulation of channel activity (e.g. G551S, G1244E, S1255P, and G1349D; Anderson and Welsh, 1992). Login to comment
101 ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:101:148
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:101:208
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:101:156
status: NEW
view ABCC7 p.Gly1069Arg details
As shown in Fig. 5, B and C, in some mutants this reduction in open probability was associated with a significant reduction in mean burst duration (F1052V, G1069R) or an increase in mean interburst duration (R1070W). Login to comment
127 ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:127:43
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:127:59
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:127:75
status: NEW
view ABCC7 p.Ala1067Thr details
Symbols are as follows: A: छ, WT; E, F1052V; Ç, K1060T; µ, A1067T; Ⅺ, vector only control. Login to comment
128 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:128:35
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:128:51
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:128:19
status: NEW
view ABCC7 p.Gly1069Arg details
B: छ, WT; E, G1069R; µ, R1070Q; Ç, R1070W; Ⅺ, control. Login to comment
129 ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 8662892:129:59
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 8662892:129:32
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Arg1066Leu
X
ABCC7 p.Arg1066Leu 8662892:129:121
status: NEW
view ABCC7 p.Arg1066Leu details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 8662892:129:105
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 8662892:129:43
status: NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 8662892:129:94
status: NEW
view ABCC7 p.Gly1061Arg details
C: छ, WT; छϩ, R1066C; E, H1054D; µ, L1065P; Ⅺ, control; Ç, G1061R, Q, R1066H; É, R1066L. Login to comment
130 ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 8662892:130:77
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 8662892:130:61
status: NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Met1101Arg
X
ABCC7 p.Met1101Arg 8662892:130:93
status: NEW
view ABCC7 p.Met1101Arg details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 8662892:130:121
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 8662892:130:43
status: NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 8662892:130:19
status: NEW
view ABCC7 p.Gln1071Pro details
D: छ, WT; E, Q1071P; छϩ, W1098R; Ⅺ, H1085R; Ç, M1101K; µ, M1101R; Q, control; É, L1077P. Login to comment
132 ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 8662892:132:121
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:132:184
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 8662892:132:82
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Arg1066Leu
X
ABCC7 p.Arg1066Leu 8662892:132:102
status: NEW
view ABCC7 p.Arg1066Leu details
ABCC7 p.Met1101Arg
X
ABCC7 p.Met1101Arg 8662892:132:132
status: NEW
view ABCC7 p.Met1101Arg details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:132:173
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 8662892:132:90
status: NEW
view ABCC7 p.Arg1066His details
Different substitutions at the same residue always produced the same effect, i.e. R1066C, R1066H, and R1066L, as well as M1101K and M1101R all inhibited maturation, whereas R1070W and R1070Q were both normally processed. Login to comment
133 ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:133:37
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:133:52
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:133:67
status: NEW
view ABCC7 p.Ala1067Thr details
Symbols are as follows: A: L, WT; E, F1052V; &#c7;, K1060T; &#b5;, A1067T; M, vector only control. Login to comment
134 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:134:28
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:134:43
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:134:13
status: NEW
view ABCC7 p.Gly1069Arg details
B: L, WT; E, G1069R; &#b5;, R1070Q; &#c7;, R1070W; M, control. Login to comment
135 ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 8662892:135:41
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 8662892:135:15
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Arg1066Leu
X
ABCC7 p.Arg1066Leu 8662892:135:94
status: NEW
view ABCC7 p.Arg1066Leu details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 8662892:135:79
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 8662892:135:26
status: NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 8662892:135:68
status: NEW
view ABCC7 p.Gly1061Arg details
C: L, WT; L 1, R1066C; E, H1054D; &#b5;, L1065P; M, control; &#c7;, G1061R, Q, R1066H; &#c9;, R1066L. Login to comment
136 ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 8662892:136:52
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 8662892:136:37
status: NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Met1101Arg
X
ABCC7 p.Met1101Arg 8662892:136:67
status: NEW
view ABCC7 p.Met1101Arg details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 8662892:136:94
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Trp1098Arg
X
ABCC7 p.Trp1098Arg 8662892:136:26
status: NEW
view ABCC7 p.Trp1098Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 8662892:136:13
status: NEW
view ABCC7 p.Gln1071Pro details
D: L, WT; E, Q1071P; L 1, W1098R; M, H1085R; &#c7;, M1101K; &#b5;, M1101R; Q, control; &#c9;, L1077P. Login to comment
138 ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 8662892:138:121
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:138:184
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 8662892:138:82
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Arg1066Leu
X
ABCC7 p.Arg1066Leu 8662892:138:102
status: NEW
view ABCC7 p.Arg1066Leu details
ABCC7 p.Met1101Arg
X
ABCC7 p.Met1101Arg 8662892:138:132
status: NEW
view ABCC7 p.Met1101Arg details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:138:173
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 8662892:138:90
status: NEW
view ABCC7 p.Arg1066His details
Different substitutions at the same residue always produced the same effect, i.e. R1066C, R1066H, and R1066L, as well as M1101K and M1101R all inhibited maturation, whereas R1070W and R1070Q were both normally processed. Login to comment
142 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:142:58
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:142:26
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:142:70
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:142:34
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:142:50
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:142:42
status: NEW
view ABCC7 p.Ala1067Thr details
A, examples of wild-type, F1052V, K1060T, A1067T, G1069R, R1070Q, and R1070W CFTR single channel currents recorded from inside-out membrane patches at a membrane potential of -30 mV. Login to comment
144 ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:144:106
status: NEW
view ABCC7 p.Gly1069Arg details
B, mean single-channel current-voltage relationships for wild type (E) and an example of a CL4 mutant (q, G1069R). Login to comment
148 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 8662892:148:58
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 8662892:148:26
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 8662892:148:70
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Lys1060Thr
X
ABCC7 p.Lys1060Thr 8662892:148:34
status: NEW
view ABCC7 p.Lys1060Thr details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:148:50
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 8662892:148:42
status: NEW
view ABCC7 p.Ala1067Thr details
A, examples of wild-type, F1052V, K1060T, A1067T, G1069R, R1070Q, and R1070W CFTR single channel currents recorded from inside-out membrane patches at a membrane potential of 230 mV. Login to comment
150 ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:150:112
status: NEW
view ABCC7 p.Gly1069Arg details
B, mean single-channel current-voltage relationships for wild type (E) and an example of a CL4 mutant (cf;, G1069R). Login to comment
155 ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:155:30
status: NEW
view ABCC7 p.Gly1069Arg details
Interestingly in murine CFTR, Gly1069 is replaced by Arg, a human mutation that we found to leave biosynthetic processing unaffected but to reduce channel open probability. Login to comment
161 ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 8662892:161:30
status: NEW
view ABCC7 p.Gly1069Arg details
Interestingly in murine CFTR, Gly1069 is replaced by Arg, a human mutation that we found to leave biosynthetic processing unaffected but to reduce channel open probability. Login to comment